CEACAM5 and hepatocellular carcinoma: HAC and HCC share many similar clinicopathological features, including elevated serum AFP, hepatoid morphology (resembling hepatocytes), and positive immunoreactivity with AFP and carcinoembryonic antigen (CEA) [7].